Application of Quality by Design in Drug Product Formulation Design & Process Development

Chair(s):
Sun, Z., Office of Process and Facilities, OPQ, CDER, FDA
Co-chair(s):
Rogers, T., The Dow Chemical Company

Pharmaceutical Quality by design (QbD) is a systematic, risk-based, scientific approach for product design and process development to ensure predefined drug product quality. It requires a thorough understanding of critical formulation attributes and critical process parameters as well as impacts of their variations on the final drug product quality. The goals of implementing pharmaceutical QbD are to reduce product variability and defects, maximize safety and efficacy for the patient, increase product development and manufacturing efficiencies, and enhance post-approval change management. This session invites presentations to demonstrate the application of QbD principles during formulation design and process development of a drug product. Papers concerning small and large molecules, including biologics, are being considered. It is intended to provide an open forum to explore how to facilitate QbD implementation in pharmaceutical industry.

Papers:

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing


Individuals

2015 AIChE Annual Meeting Proceedings
AIChE Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $225.00
Pharmaceutical Discovery, Development and Manufacturing Forum only
AIChE Members $100.00
AIChE Food, Pharmaceutical & Bioengineering Division Members Free
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
Non-Members $150.00